| Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer (NCT06583655) | Ruijin Hospital | 2024-10-01 |
| The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis Patients (NCT06697418) | Ruijin Hospital | 2024-10-01 |
| The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer. (NCT06601010) | Ruijin Hospital | 2024-09-24 |
| Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors (NCT06577532) | Ruijin Hospital | 2024-09-24 |
| The Efficacy of Allo-HSCT in ND HR-CBF-AML (NCT06458244) | Ruijin Hospital | 2024-09-21 |
| First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure (NCT06621576) | Ruijin Hospital | 2024-09-18 |
| Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai (NCT06641856) | Ruijin Hospital | 2024-09-02 |
| Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC (NCT06573398) | Ruijin Hospital | 2024-09-01 |
| Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL (NCT06573151) | Ruijin Hospital | 2024-09-01 |
| A Real-World Study on Extranodal Lymphoma (NCT06573099) | Ruijin Hospital | 2024-09-01 |
| CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors (NCT06567366) | Ruijin Hospital | 2024-09-01 |
| Current Situation of Health Care in Women With HBV or HCV Infection (NCT06579313) | Ruijin Hospital | 2024-09-01 |
| Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCL (NCT06573138) | Ruijin Hospital | 2024-09-01 |
| Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer (NCT06538623) | Ruijin Hospital | 2024-08-23 |
| Antithrombotic Therapy With Regulation of Blood Pressure in Non-Cardioembolic Progressive Stroke (NCT06551727) | Ruijin Hospital | 2024-08-15 |
| Study on Postoperative Adrenal Function Assessment in Patients With Primary Aldosteronism (NCT06534268) | Ruijin Hospital | 2024-08-15 |
| Predictive Role of KLK10 and Other Neuroinflammatory Molecules on Clinical Outcomes of AIS (NCT06549972) | Ruijin Hospital | 2024-08-12 |
| Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE) (NCT06534463) | Ruijin Hospital | 2024-08-02 |
| A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice (NCT06541340) | Ruijin Hospital | 2024-08-01 |
| The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma (NCT06522555) | Ruijin Hospital | 2024-07-29 |
| Amygdala TIS for Depression (NCT06477276) | Ruijin Hospital | 2024-07-24 |
| PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma (NCT06755775) | Ruijin Hospital | 2024-07-23 |
| The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer (NCT06623487) | Ruijin Hospital | 2024-07-19 |
| Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer (NCT06496373) | Ruijin Hospital | 2024-07-16 |
| Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment (NCT06496308) | Ruijin Hospital | 2024-07-10 |
| Real-world Study of Acalabrutinib (NCT06767891) | Ruijin Hospital | 2024-07-02 |
| Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - IV (NCT06793787) | Ruijin Hospital | 2024-07-01 |
| Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - III (NCT06793774) | Ruijin Hospital | 2024-07-01 |
| Effect of Oxycodone on Anxiety State in Painless Abortion (NCT06435949) | Ruijin Hospital | 2024-07-01 |
| A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma (NCT06494371) | Ruijin Hospital | 2024-07-01 |
| Blinatumomab Maintenance After Allo-HSCT (NCT06438796) | Ruijin Hospital | 2024-07-01 |
| Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma (NCT06596954) | Ruijin Hospital | 2024-06-30 |
| 68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer. (NCT06608160) | Ruijin Hospital | 2024-06-20 |
| A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence (NCT06468709) | Ruijin Hospital | 2024-06-20 |
| The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis. (NCT06597526) | Ruijin Hospital | 2024-06-15 |
| Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR (NCT06297772) | Ruijin Hospital | 2024-06-01 |
| Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study (NCT06482788) | Ruijin Hospital | 2024-05-22 |
| Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection (NCT06541327) | Ruijin Hospital | 2024-05-15 |
| Analysis of Deep Brain Nuclei LFP and Cortical EEG Signals During the Recovery From General Anesthesia (NCT06400901) | Ruijin Hospital | 2024-05-15 |
| A Multimodal Prospective Cohort Study of Parkinsonism (NCT07553845) | Ruijin Hospital | 2024-05-01 |
| Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer (NCT06368141) | Ruijin Hospital | 2024-05-01 |
| Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients (NCT06404697) | Ruijin Hospital | 2024-05-01 |
| An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3). (NCT06339060) | Ruijin Hospital | 2024-05-01 |
| a Ultrasonographic Measurement of Intra-abdominal Pressure (NCT06390605) | Ruijin Hospital | 2024-05-01 |
| Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression (NCT06269211) | Ruijin Hospital | 2024-04-20 |
| CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors (NCT06365671) | Ruijin Hospital | 2024-04-16 |
| In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor (NCT06246630) | Ruijin Hospital | 2024-04-03 |
| PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions (NCT06602674) | Ruijin Hospital | 2024-04-01 |
| Cognitive Impairment Cohort Study of the Elderly Population in YuGarden (NCT06325527) | Ruijin Hospital | 2024-04-01 |
| Effect of Belimumab on Antibody Titers in Primary APS Patients (NCT06747312) | Ruijin Hospital | 2024-04-01 |
| a Feasibility Study of iHD-SRT for BM (NCT06231186) | Ruijin Hospital | 2024-03-15 |
| Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS (NCT06247917) | Ruijin Hospital | 2024-03-03 |
| The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma (NCT06255795) | Ruijin Hospital | 2024-02-15 |
| A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML (NCT06329999) | Ruijin Hospital | 2024-02-03 |
| 12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease (NCT07034222) | Ruijin Hospital | 2024-02-01 |
| Organ Protective Effect of Cetirizine In Patients With Severe Burns (NCT06126991) | Ruijin Hospital | 2024-01-23 |
| Ultrasound Assessment of Isolated Distal Deep Vein Thrombosis (NCT06596941) | Ruijin Hospital | 2024-01-01 |
| Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors (NCT05916248) | Ruijin Hospital | 2023-12-20 |
| Follow-up Study of Autologous Transplantation of P63+ Lung Progenitor Cells for Treatment of Bronchiectasis (NCT06164093) | Ruijin Hospital | 2023-12-12 |
| PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma (NCT06069830) | Ruijin Hospital | 2023-12-06 |
| Effect of Telitacicept on Antibody Titers in Primary APS Patients (NCT06315530) | Ruijin Hospital | 2023-12-01 |
| Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer (NCT06146985) | Ruijin Hospital | 2023-12-01 |
| Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma (NCT06876688) | Ruijin Hospital | 2023-11-30 |
| A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT06136351) | Ruijin Hospital | 2023-11-15 |
| Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT (NCT06177561) | Ruijin Hospital | 2023-11-09 |
| The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy (NCT06119880) | Ruijin Hospital | 2023-11-01 |
| Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features (NCT06604377) | Ruijin Hospital | 2023-11-01 |
| Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL (NCT06062641) | Ruijin Hospital | 2023-10-30 |
| Remote Programming for Deep Brain Stimulation in Parkinson's Disease. (NCT06078397) | Ruijin Hospital | 2023-10-30 |
| Valuate the Clinical Performance and Safety of da Vinci SP Surgical System (NCT06246617) | Ruijin Hospital | 2023-10-25 |
| (CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL) (NCT05923502) | Ruijin Hospital | 2023-10-20 |
| De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC (NCT06572514) | Ruijin Hospital | 2023-10-17 |
| Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research (NCT06049381) | Ruijin Hospital | 2023-10-01 |
| Real-World Study of DLBCL With Different Genetic Subtypes (NCT06026488) | Ruijin Hospital | 2023-10-01 |
| Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment (NCT06028217) | Ruijin Hospital | 2023-10-01 |
| The Role of Bifidobacterium Intervention in Food Allergic Infants (NCT05965063) | Ruijin Hospital | 2023-09-01 |
| Individual Neuromodulation for PDS (NCT06193278) | Ruijin Hospital | 2023-09-01 |
| Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment (NCT06534489) | Ruijin Hospital | 2023-08-31 |
| Artificial Intelligence (AI) Analysis of Synchronized Phonocardiography (PCG) and Electrocardiogram(ECG) (NCT06009718) | Ruijin Hospital | 2023-08-25 |
| Single-lumen Endotracheal Intubation in ENB-guided Localization and Resection of Pulmonary Nodules (NCT07288255) | Ruijin Hospital | 2023-08-01 |
| Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer (NCT05976412) | Ruijin Hospital | 2023-07-28 |
| Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT (NCT05896007) | Ruijin Hospital | 2023-07-13 |
| Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST) (NCT05934864) | Ruijin Hospital | 2023-07-13 |
| Risk Evaluation by COronary CTA and Artificial IntelliGence Based fuNctIonal analyZing tEchniques - II (NCT05856110) | Ruijin Hospital | 2023-07-03 |
| A Clinical Validation Study to Evaluate the Diagnostic Accuracy of a Cough-based Auxiliary Diagnosis Algorithm for COPD (NCT06082791) | Ruijin Hospital | 2023-07-01 |
| A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types (NCT05907447) | Ruijin Hospital | 2023-07-01 |
| Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma (NCT05923879) | Ruijin Hospital | 2023-06-30 |
| A Combination Study of CAR-T Therapy in r/r B-NHL (NCT05871684) | Ruijin Hospital | 2023-06-10 |
| A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL (NCT05899621) | Ruijin Hospital | 2023-06-01 |
| PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) (NCT06074692) | Ruijin Hospital | 2023-06-01 |
| Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial (NCT06114225) | Ruijin Hospital | 2023-06-01 |
| PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma (NCT05662540) | Ruijin Hospital | 2023-05-26 |
| Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease (NCT05887674) | Ruijin Hospital | 2023-05-11 |
| Real World Study of Linperlisib for Lymphoma Treatment (NCT05863871) | Ruijin Hospital | 2023-05-01 |
| Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer (NCT05749211) | Ruijin Hospital | 2023-05-01 |
| Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma (NCT05806580) | Ruijin Hospital | 2023-05-01 |
| Risk Evaluation by COronary CTA and Artificial intelliGence Based fuNctIonal analyZing tEchniques - I (NCT05884008) | Ruijin Hospital | 2023-05-01 |
| Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer (NCT05916261) | Ruijin Hospital | 2023-04-26 |
| Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN (NCT06589752) | Ruijin Hospital | 2023-04-24 |
| Timings for Awake Prone Positioning in Covid-19 Patients (NCT05795751) | Ruijin Hospital | 2023-04-01 |